ACCURAY WKN: A0MKWM ISIN: US0043971052 Kürzel: XEJ Forum: Aktien Thema: Hauptdiskussion

10-Year Data Shows Accuray CyberKnife® System Provides Long-Lasting Relief of the Excruciating Pain Caused by Trigeminal Neuralgia https://www.biospace.com/article/releases/10-year-data-shows-accuray-cyberknife-system-provides-long-lasting-relief-of-the-excruciating-pain-caused-by-trigeminal-neuralgia/

CARTI Selects Accuray CyberKnife® S7™ System to Increase Access to Advanced Cancer Care for Patients in Rural Communities Throughout Arkansas CARTI is First in Arkansas to Treat Patients with World's Only Robotic Radiosurgery System https://www.prnewswire.com/news-releases/carti-selects-accuray-cyberknife-s7-system-to-increase-access-to-advanced-cancer-care-for-patients-in-rural-communities-throughout-arkansas-301497478.html

https://www.prnewswire.com/news-releases/largest-hospital-in-queensland-australia-acquires-multiple-accuray-radixact-systems-with-the-clearrt-helical-fan-beam-kvct-imaging-and-synchrony-technologies-301481340.html

https://www.benzinga.com/node/25532597

Accuray GAAP EPS of $0.00 in-line, revenue of $116.28M beats by $13.35M https://seekingalpha.com/news/3792078-accuray-gaap-eps-of-0_00-in-line-revenue-of-116_28m-beats-13_35m FQ2 GAAP EPS of $0.00 in-line. Revenue of $116.28M (+19.3% Y/Y) beats by $13.35M. Gross orders of $85.4 million, an increase of 13 percent compared to the prior year. Revising guidance 2022: Total revenue is being increased to an expected range of $420.0 million to $430.0 million compared to the prior range of $420.0 million to $427.0 million, representing a year-over-year growth at the midpoint of the range of 7%. Adjusted EBITDA is now expected to range between $15.0 million to $20.0 million compared to the prior range of $33.0 million to $35.0 million.

Accuray Reports Fiscal 2022 Second Quarter Financial Results https://finance.yahoo.com/news/accuray-reports-fiscal-2022-second-210500213.html

https://www.prnewswire.com/news-releases/accuray-cyberknife-robotic-radiosurgery-system-receives-shonin-approval-to-treat-trigeminal-neuralgia-a-chronic-pain-condition-affecting-a-facial-nerve-301445066.html Accuray CyberKnife® Robotic Radiosurgery System Receives Shonin Approval to Treat Trigeminal Neuralgia, a Chronic Pain Condition Affecting a Facial Nerve - Trigeminal neuralgia, a persistent neurological disorder, is described by some patients as the most excruciating pain human beings can experience(1) - The approval expands global patient access to the CyberKnife System, an effective, non-invasive treatment alternative to surgery

Accuray Granted U.S. Patent #11,191,511 'Method and apparatus for image reconstruction and correction using inter-fractional information' https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6478&f=G&l=50&d=PTXT&p=130&S1=20211207&OS=20211207&RS=20211207

Accuray CyberKnife® Robotic Radiotherapy Platform Expands Range of Neurological Indications That Can Be Effectively Treated With Stereotactic Radiosurgery https://finance.yahoo.com/news/accuray-cyberknife-robotic-radiotherapy-platform-123000176.html

Accuray Files For U.S. Patent Titled 'Noise and artifact reduction for image scatter correction' https://www.benzinga.com/news/21/11/23989501/accuray-files-for-u-s-patent-titled-noise-and-artifact-reduction-for-image-scatter-correction

👍 stark!

Accuray Reports Fiscal 2022 First Quarter Financial Results https://www.prnewswire.com/news-releases/accuray-reports-fiscal-2022-first-quarter-financial-results-301415674.html

Accuray US Patent & Trademark Office Abstract for Co.s 'Method and apparatus for scatter estimation in cone-beam computed tomography' https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6469&f=G&l=50&d=PTXT&p=130&S1=20211102&OS=20211102&RS=20211102

Accuray jumps to a six-month high as investor website touts the stock https://seekingalpha.com/news/3760930-accuray-jumps-to-a-six-month-high-as-investor-website-touts-the-stock Shares of Accuray Incorporated (ARAY +14.6%) surged in morning hours triggering a trading halt after the investor website Banyan Hill recommended buying the stock in a flash alert. With the biggest intraday gain since August 2020, Accuray (NASDAQ:ARAY) shares have reached the highest level since April. Over 9.7M shares have changed hands, compared to the 65-day average of ~0.7M. ...

Klasse 😇